The U.S. Food and Drug Administration, FDA, has granted Omega Medical Imaging clearance through the 510(k) process to offer their Artificial Intelligence powered Region of Interest (ROI) Radiation exposure reduction solution for interventional X-ray imaging on their Flat Panel detector CS-series product lines.
SANFORD, Fla., April 11, 2019 /PRNewswire/ -- Omega Medical Imaging announces the launch of FluoroShield™ in conjunction with technology partner IKOMED Technologies, Vancouver, BC Canada. FluoroShield™ is an Artificial Intelligence powered Region of Interest (ROI) Radiation exposure reduction solution for interventional X-ray imaging available only on Omega's Flat Panel detector CS-series product lines.
FluoroShield™ combines the power of AI, an ultra-fast collimator and the worlds most advanced image processing to deliver a Region of Interest solution that has shown to reduce radiation exposure up to ~84 percent, seamlessly helping Interventional clinicians better reach their ALARA goals.
Omega Medical Imaging LLC based in Sanford Florida USA is an innovator in the design, manufacture, delivery, and support of Interventional X-Ray Imaging devices for hospitals and healthcare facilities around the globe.
IKOMED Technologies Inc, Vancouver, BC Canada is a medical device company developing novel medical solutions based on proprietary technology.
Details can be found at https://www.omegamedicalimaging.com.
Contact:
Megan Grosz
Omega Medical Imaging, LLC.
1-407-323-9400 X212
mgrosz@omegamedicalimaging.com
Megan Grosz
Omega Medical Imaging, LLC.
1-407-323-9400 X212
mgrosz@omegamedicalimaging.com
No comments:
Post a Comment